Monoclonal antibody NM01

Drug Profile

Monoclonal antibody NM01

Alternative Names: hNM01

Latest Information Update: 12 Sep 2007

Price : $50

At a glance

  • Originator SRD Pharmaceuticals
  • Class Antivirals; Monoclonal antibodies
  • Mechanism of Action HIV replication inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued HIV infections

Most Recent Events

  • 13 May 2004 SRD Pharmaceuticals has acquired all patents related to hNM01
  • 02 Sep 2002 Preclinical trials in HIV infections treatment in Canada (unspecified route)
  • 15 Aug 2002 Immune Network and AbNovo will collaborate in the development of antibody-based therapeutics for viral diseases.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top